SCHEMBL276310

SCHEMBL276310

Cc1ccc(S(=O)(=O)CN=C=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ MCHR1 Q99705 2/20 0.44
▸ CTSK P43235 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13963075 0.83 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL4531239 0.83 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL6981568 0.81 ALDH1A1 (0.58) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
Hydrochloric Acid SCHEMBL28969079 0.81 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL16589253 0.80 ALDH1A1 (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL1952786 0.80 PSIP1 (0.50) ALDH1A1KMT2AMEN1GAACA12
SCHEMBL14445541 0.79 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL16592125 0.76 ALDH1A1 (0.43) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL12189513 0.76 ALDH1A1 (0.55) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL2218966 0.76 ALDH1A1 (0.55) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116444198-B Integral hydrophobic material of fat-based silicon high-strength concrete and preparation method thereof 西安科技大学 2024-05-03 — — CN claimed
CN-116589341-A Preparation method of antihyperlipidemic drug intermediate 苏州汉德创宏生化科技有限公司 2023-08-15 — — CN claimed
CN-116444198-A Integral hydrophobic material of fat-based silicon high-strength concrete and preparation method thereof 西安科技大学 2023-07-18 — — CN claimed
CN-115425292-A High-temperature-resistant electrolyte, secondary battery and application thereof 华中科技大学 2022-12-02 — — CN claimed
CN-113614063-A Method for synthesizing anthranilamide compound and intermediate thereof PI工业有限公司 2021-11-05 — — CN claimed
CN-106244067-B Method for producing viscous epoxide slurries and epoxide slurries obtained according to said method 德莎欧洲股份公司 2021-06-01 — — CN claimed
CN-106244066-B Water vapor barrier adhesives with initially polymerized epoxy paste 德莎欧洲股份公司 2021-05-11 — — CN claimed
EP-3101047-B1 METHOD FOR PRODUCING VISCOUS EPOXIDE SYRUPS AND EPOXIDE SYRUPS OBTAINABLE THEREFROM TESA SE (DE) 2020-12-30 — — EP claimed
EP-3101079-B1 STEAM BLOCKING ADHESIVE WITH ANPOLYMERISED EPOXIDE SYRUP TESA SE (DE) 2019-10-23 — — EP claimed
CN-106244067-A The method preparing viscous epoxy compound slurry and the epoxide slurry obtained according to the method 德莎欧洲公司 2016-12-21 — — CN claimed
EP-4746963-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 — — EP disclosed
WO-2026098560-A2 BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2026-05-15 — — WO disclosed
CN-121108039-A Preparation method of piperidone containing amino protection 国药国际医药科技(北京)有限公司 2025-12-12 — — CN disclosed
CN-120129674-A Cationic lipids and methods of making the same 三养控股公司 2025-06-10 — — CN disclosed
EP-4555033-A1 UNCROSSLINKED POLYEPOXIDE AND ADHESIVE COMPOUND COMPRISING SAID POLYEPOXIDE TESA SE (DE) 2025-05-21 — — EP disclosed
US-5196542-A Phospholipase A2 inhibitors THE UPJOHN COMPANY (US) 1993-03-23 — — US disclosed
US-5187299-A Phospholipase inhibitors; treating diabetes, obesity THE UPJOHN COMPANY (US) 1993-02-16 — — US disclosed
US-5145874-A Phospholipase inhibitor, hypoglycemic agent, antidiabetic, obesity THE UPJOHN COMPANY (US) 1992-09-08 — — US disclosed
US-4917826-A TREATING DIABETES AND OBESITY THE UPJOHN COMPANY (US) 1990-04-17 — — US disclosed
EP-0030749-B1 CARBOXIMIDAMIDE DERIVATIVES, A PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME AKZO N.V. (NL) 1983-08-17 — — EP disclosed
Send feedback